About
We invite you to join us for an immersion workshop focusing on the improvement of preclinical translation in Alzheimer’s Disease research. This workshop will leverage the expertise of the Model Organism Development for Evaluation of Late Onset Alzheimer’s Disease (MODEL-AD) Precision Medicine consortium. We aim to address training gaps in preclinical drug screening by providing you with the skills and knowledge required for rigorous design, execution, analysis, and reporting of pharmacokinetic, pharmacodynamics, and preclinical efficacy experiments. Additionally, we will focus on the selection and appropriate use of mouse models in translational research and specific hands-on techniques.
*This workshop can be used for continuing education units for AALAS re-certification.
Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number R13AG060708. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The 2021 check-in date will be Sunday April 25th and the check-out date will be Saturday, May 1st.
Air
